Wednesday, March 03, 2021 12:42:49 PM
Just to add.. the belief that MW "bailed" on less-than-stellar results, from a study that he himself hasn't had a chance to review, is ludicrous.
As if, in some alternate universe, running from your work is a form of career advancement.
The research science on Ifenprodil, and the rest of the pipeline to an extent, is complete. His work on identifying compounds and the repurposing strategy that goes along with it are now Algernon's to explore. Time to move on.
Now back to swiping up a few more discounted tickets.
To think some clueless posters will sway me at this point in the game is funny AF.
It's ride..or die time up in this bit*h!
Let's roll!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM